English
HOME
Greeting
General Information
Call for Abstracts
Call for abstracts of Foreign Invited Speakers
Program
Early Registration
Medical / Morning / Evening / Seminar
Access
Accommodation
Links
KOBE CONVENTION BUREAU
Feel KOBE + Discovering the Joy of Kobe
 
Facebook
プログラム
*As of March 31,2018  
President's Special Program
 
Special Lecture
 
Joint Symposium
International Symposium
 
Symposium
 
Medical Staff Program
 
  President's Special Program
  Afternoon, July 19 (Thu.)
  Special Lecture
1
  The BCAA metabolism pathway maintains the stemness of human acuteleukemia
    July 19 (Thu.)
2
  AI
    Afternoon, July 19 (Thu.)
3
  Patient Reported Outcomes in Oncology
    Morning, July 21 (Sat.)
  ASCO/JSMO Joint Symposium
  Precision medicine: current status and future perspectives
  Afternoon, July 19 (Thu.)
  ESMO/JSMO Joint Symposium
  Health Economics and Medical Care
  Afternoon, July 20 (Fri.)
  ASIA Oceania/JSMO Joint Symposium
  Investigator initiated clinical trials in Asia, its current issues and future perspectives
  Morning, July 19 (Thu.)
 
SIOG/JSMO Joint Symposium   Under the auspices of
  All oncologists are geriatric oncologists
  Afternoon, July 19 (Thu.)
  Asia Oceania Leaders’ Symposium
  Morning, July 21 (Sat.)
  Joint Symposium
1
  Cancer genomics
    (JCA/JSCO/JSMO)
    Morning, July 19 (Thu.)
2
  Integration of oncology and palliative care
    (JSPM/JSMO)
    Morning, July 19 (Thu.)
3
  New treatment strategies using anticancer agents and radiation in the era of precision medicine
    (JASTRO/JSMO)
    Afternoon, July 19 (Thu.)
4
  Onco-cardiology leaned from cases
    (JCS/JSMO)
    Morning, July 20 (Fri.)
5
  The latest trend of Health Technology Assessment (HTA) in Japan and
Optimal Clinical Use Guidelines
    (JAPhMed/JSMO)
    Morning,July 21 (Sat.)
6
  Perspective of safe handling of cancer chemotherapy drugs in Japan
    (JSCN/JSMO)
    Morning, July 21 (Sat.)
  International Symposium
1
  New treatment modality for GI cancer
    Afternoon, July 19 (Thu.)
2
  Advance of systemic therapy for hepatocellular carcinoma
    Afternoon, July 19 (Thu.)
3
  Precision endocrine therapy for advanced/metastatic breast cancer; best choice and best sequence
    Afternoon, July 19 (Thu.)
4
  Molecular diagnosis for treatment of colorectal cancer
    Morning, July 20 (Fri.)
5
  Immunotherapies for Head and Neck Cancer
    Morning, July 20 (Fri.)
6
  Future Perspectives of PARP inhibitor
    Morning, July 20 (Fri.)
7
  Immunotherapy in lung cancer
    Morning, July 21 (Sat.)
8
  Clinical practice guidelines in Japan, Asia and the world
    Afternoon, July 21 (Sat.)
9
  New therapeutic strategies for lymphoid malignancies
    Morning, July 21 (Sat.)
10
  Future perspectives of treatment for NSCLC
    Morning, July 21 (Sat.)
  Symposium
1
  Immunotherapy: New development
    Morning, July 19 (Thu.)
2
  Diagnosis and treatment strategy for NSCLC with rare driver mutations
    Afternoon, July 19 (Thu.)
3
  Development of multidisciplinary therapy for esophgeal cancer
    Morning, July 19 (Thu.)
4
  Genomic medicine in the promotion plan for the human resource development for cancer
    Afternoon, July 19 (Thu.)
5
  Multidisciplinary treatment for head and neck cancer
    Afternoon, July 19 (Thu.)
6
  Current status and perspective of treatment for adolescents and young adults with cancer
    Morning, July 19 (Thu.)
7
  Immunotherapy & targeted therapy for melanoma & renal cancer: strategic similarity & difference
    Afternoon, July 19 (Thu.)
8
  Chemotherapy in pregnancy
    Afternoon, July 19 (Thu.)
9
  Cancer patients with delirium : A multidisciplinary approach
    Morning, July 19 (Thu.)
10
  Future prospects of genome-based medicine in Japan
    Afternoon, July 20 (Fri.)
11
  Liquid biopsy
    Morning, July 20 (Fri.)
12
  Current strategy for EGFR mutant NSCLC
    Afternoon, July 20 (Fri.)
13
  Angiogenesis inhibitor for gastrointestinal tumors
    Afternoon, July 20 (Fri.)
14
  Thequential therapy for urological cancer
    Afternoon, July 20 (Fri.)
15
  Evolution of therapeutic concepts for hematologic malignancies
    Morning, July 20 (Fri.)
16
  Dose-dense TC vs TC+BEV as primary chemotherapy for ovarian cancer
    Afternoon, July 20 (Fri.)
17
  Palliative care up-to-date
    Morning, July 20 (Fri.)
18
  Communication
    Afternoon, July 20 (Fri.)
19
  Bridging cancer survivorship research and practice gap
    Afternoon, July 20 (Fri.)
    Co-sponsor: Eli Lilly Japan K.K.
20
  Multidisciplinary care to assist cancer patients to keep working
    Morning, July 20 (Fri.)
21
  New target therapies for soft tissue sarcoma
    Afternoon, July 20 (Fri.)
22
  Clinical Research Act
    Morning, July 21 (Sat.)
23
  Countermeasures against side effects by immune checkpoint inhibitors
    Afternoon, July 21 (Sat.)
24
  Acquired resistance to molecular targeted therapy and strategy for overcoming
    Morning, July 21 (Sat.)
25
  Clinical development among rare cancer
    Morning, July 21 (Sat.)
26
  Today and tomorrow in the elderly cancer care
    Morning, July 21 (Sat.)
27
  Therapeutic strategies for triple negative breast cancer
    Morning, July 21 (Sat.)
28
  Pancreatic cancer treatment in the future
    Afternoon, July 21 (Sat.)
29
  Management of hereditary cancer
    Morning, July 21 (Sat.)
30
  Treatment of rare cancers: coalition and centralization
    Afternoon, July 21 (Sat.)
  Medical Staff Program
1
  How to support adlescent and young adults with cancer
    Afternoon, July 19 (Thu.)
2
  Automation of preparation of anticancer agents
- current status and future prospects-
    Morning, July 20 (Fri.)
3
  Genomic medicine and genetic counseling for nurse
    Morning, July 21 (Sat.)
4
  Break the barrier of the medical staff outpatients
    Afternoon, July 21 (Sat.)
 
 
 
 
  Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University
3-1-1, Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
  c/o Congress Corporation
1-9-17 Tenjin Chuo-ku, Fukuoka, Japan
Phone: +81-92-716-7116
Fax: +81-92-716-7143
E-mail: jsmo2018@congre.co.jp
Copyright© 2018 The Japanese Society of Medical Oncology Annual Meeting All Rights Reserved.